BIT 0.00% 2.5¢ biotron limited

this should have a market cap of 100 million +, page-111

  1. 3,643 Posts.
    lightbulb Created with Sketch. 548
    Nn Littlecorn, the new trial for both G1 and G3 patients for a 12 week dosing period. Once again this puts to bed the silly comments somebody was making about Biotron deliberately avoiding G1 patients LOL. Who was that?

    PS. Did I mention that the trial is fully funded therefore no need for a CR?
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.